NASDAQ: LYEL - Lyell Immunopharma, Inc.
Доходность за полгода: +23.9%
Сектор: Healthcare
Lyell Immunopharma, Inc. Форум акций| Параметр | Оценка | Значение | Среднее по сектору | Разница с сектором, % | Средняя за 5 лет | Разница со средней, % |
|---|---|---|---|---|---|---|
| P/E | -2.4 | 48.18 | -104.97% | 3.73 | -164.26% | |
P/E Forward 
|
|
-2.44 | 3.73 | -165.54% | ||
| P/S |
|
4325.38 | 33.76 | 12711.81% | 73.01 | 5824.37% |
| P/S Forward |
|
0 | 73.01 | -100% | ||
| P/BV |
|
0.8634 | 4.84 | -82.17% | 1.2367 | -30.19% |
| P/BV Forward |
|
1.2298 | 1.2367 | -0.5554% | ||
| Ev/Ebitda |
|
-2.11 | -23.25 | -90.91% | -1.0261 | 106.09% |
| Ev/Ebitda Forward |
|
-4.7 | -1.0261 | 357.65% |
